Conversely, the SPDR S&P Biotech ETF displays more volatility, like high-beta stocks.
"History suggests that while S&P is likely to continue rallying from here, high beta will not continue to outperform to the same degree," said Chintan Kotecha, an analyst at BAML, in a note to clients. The same up-then-down pattern has historically occurred within the biotech sector, and provides a way for traders to profit from a likely slowdown in high-beta stocks, Kotecha said.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Watch TD Bank CEO and Visa president discuss the future of financeTop executives at TD Bank, Visa and online small-business-lending firm OnDeck will discuss the future of finance. Looks like we are ending the federal reserve
อ่านเพิ่มเติม »
Stocks making the biggest moves midday: Deutsche Bank, Nielsen, Movado & moreThese are the stocks posting the largest moves midday Thursday. Deutsche Bank - Strong buy!
อ่านเพิ่มเติม »